MetaADEDB 2.0 @ LMMD
tofacitinib
(SYIKUFDOYJFGBQ-YLAFAASESA-N)
Structure
SMILES
OC(=O)C(CC(=O)O)(CC(=O)O)O.N#CCC(=O)N1CC[C@H]([C@H](C1)N(c1ncnc2c1cc[nH]2)C)C
Molecular Formula:
C22H28N6O8
Molecular Weight:
504.493
Log P:
0.2342
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
5
TPSA:
221.04
CAS Number(s):
540737-29-9
Synonym(s)
1.
tofacitinib
2.
CP 690,550
3.
CP 690550
4.
CP-690,550
5.
CP-690550
6.
CP690550
7.
Xeljanz
8.
tasocitinib
9.
tofacitinib citrate
External Link(s)
MeSHC479163
PubChem Compound10174505
ChEBI71197
CHEMBLCHEMBL2103743
KEGGdr:D09783
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 4503
Canada Vigilance: 596
Canada Vigilance
US FAERS
2PainFAERS: 2815
Canada Vigilance: 79
Canada Vigilance
US FAERS
3ArthralgiaFAERS: 2770
Canada Vigilance: 55
Canada Vigilance
US FAERS
4HeadacheFAERS: 2301
Canada Vigilance: 160
Canada Vigilance
US FAERS
5MalaiseFAERS: 2211
Canada Vigilance: 72
Canada Vigilance
US FAERS
6FatigueFAERS: 1903
Canada Vigilance: 120
Canada Vigilance
US FAERS
7NasopharyngitisFAERS: 1543
Canada Vigilance: 85
Canada Vigilance
US FAERS
8Musculoskeletal stiffnessFAERS: 1347
Canada Vigilance: 20
Canada Vigilance
US FAERS
9Joint swellingFAERS: 1310
Canada Vigilance: 36
Canada Vigilance
US FAERS
10NauseaFAERS: 1250
Canada Vigilance: 91
Canada Vigilance
US FAERS
11Peripheral swellingFAERS: 1071
Canada Vigilance: 59
Canada Vigilance
US FAERS
12SinusitisFAERS: 970
Canada Vigilance: 24
Canada Vigilance
US FAERS
13InfluenzaFAERS: 929
Canada Vigilance: 49
Canada Vigilance
US FAERS
14Urinary tract infectionFAERS: 900
Canada Vigilance: 17
Canada Vigilance
US FAERS
15PneumoniaFAERS: 868
Canada Vigilance: 53
Canada Vigilance
US FAERS
16Back PainFAERS: 840
Canada Vigilance: 42
Canada Vigilance
US FAERS
17InfectionFAERS: 754
Canada Vigilance: 23
Canada Vigilance
US FAERS
18BronchitisFAERS: 658
Canada Vigilance: 21
Canada Vigilance
US FAERS
19DizzinessFAERS: 656
Canada Vigilance: 46
Canada Vigilance
US FAERS
20Drug dose omissionFAERS: 654US FAERS
21Abdominal discomfortFAERS: 649
Canada Vigilance: 45
Canada Vigilance
US FAERS
22Drug effect incompleteFAERS: 644US FAERS
23Product use issueFAERS: 610
Canada Vigilance: 29
Canada Vigilance
US FAERS
24Oropharyngeal painFAERS: 598
Canada Vigilance: 35
Canada Vigilance
US FAERS
25Blood cholesterol increasedFAERS: 525
Canada Vigilance: 12
Canada Vigilance
US FAERS
26AlopeciaFAERS: 510
Canada Vigilance: 10
Canada Vigilance
US FAERS
27SwellingFAERS: 492
Canada Vigilance: 14
Canada Vigilance
US FAERS
28Musculoskeletal PainFAERS: 482
Canada Vigilance: 22
Canada Vigilance
US FAERS
29VomitingFAERS: 480
Canada Vigilance: 30
Canada Vigilance
US FAERS
30Product dose omissionFAERS: 478
Canada Vigilance: 57
Canada Vigilance
US FAERS
31Product use in unapproved indicationFAERS: 478
Canada Vigilance: 2
Canada Vigilance
US FAERS
32Rheumatoid ArthritisFAERS: 462
Canada Vigilance: 73
Canada Vigilance
US FAERS
33MyalgiaFAERS: 460
Canada Vigilance: 13
Canada Vigilance
US FAERS
34AstheniaFAERS: 454
Canada Vigilance: 32
Canada Vigilance
US FAERS
35Feeling abnormalFAERS: 406
Canada Vigilance: 13
Canada Vigilance
US FAERS
36Abdominal PainFAERS: 379
Canada Vigilance: 17
Canada Vigilance
US FAERS
37ConstipationFAERS: 376
Canada Vigilance: 24
Canada Vigilance
US FAERS
38Joint Range of Motion DecreasedFAERS: 368
Canada Vigilance: 3
Canada Vigilance
US FAERS
39SynovitisFAERS: 367
Canada Vigilance: 1
Canada Vigilance
US FAERS
40Therapeutic response unexpectedFAERS: 333
Canada Vigilance: 12
Canada Vigilance
US FAERS
41ArthropathyFAERS: 330
Canada Vigilance: 21
Canada Vigilance
US FAERS
42PruritusFAERS: 326
Canada Vigilance: 8
Canada Vigilance
US FAERS
43Joint stiffnessFAERS: 324
Canada Vigilance: 5
Canada Vigilance
US FAERS
44Intentional product misuseFAERS: 321
Canada Vigilance: 24
Canada Vigilance
US FAERS
45DyspepsiaFAERS: 312
Canada Vigilance: 22
Canada Vigilance
US FAERS
46ArthritisFAERS: 279
Canada Vigilance: 5
Canada Vigilance
US FAERS
47Chest PainFAERS: 256
Canada Vigilance: 12
Canada Vigilance
US FAERS
48AnxietyFAERS: 248
Canada Vigilance: 12
Canada Vigilance
US FAERS
49Neck PainFAERS: 248
Canada Vigilance: 5
Canada Vigilance
US FAERS
50Weight decreasedFAERS: 238
Canada Vigilance: 10
Canada Vigilance
US FAERS
51HypersensitivityFAERS: 234
Canada Vigilance: 5
Canada Vigilance
US FAERS
52Memory impairmentFAERS: 232
Canada Vigilance: 5
Canada Vigilance
US FAERS
53Cerebrovascular accidentFAERS: 221
Canada Vigilance: 7
Canada Vigilance
US FAERS
54CystitisFAERS: 208
Canada Vigilance: 14
Canada Vigilance
US FAERS
55ErythemaFAERS: 203
Canada Vigilance: 13
Canada Vigilance
US FAERS
56Drug ineffective for unapproved indicationFAERS: 197US FAERS
57Therapy cessationFAERS: 190US FAERS
58AcneFAERS: 182
Canada Vigilance: 4
Canada Vigilance
US FAERS
59ChillsFAERS: 179
Canada Vigilance: 8
Canada Vigilance
US FAERS
60Loss of personal independence in daily activitiesFAERS: 176
Canada Vigilance: 14
Canada Vigilance
US FAERS
61Pre-existing condition improvedFAERS: 173
Canada Vigilance: 5
Canada Vigilance
US FAERS
62Myocardial InfarctionFAERS: 160
Canada Vigilance: 8
Canada Vigilance
US FAERS
63SomnolenceFAERS: 158
Canada Vigilance: 10
Canada Vigilance
US FAERS
64InflammationFAERS: 153
Canada Vigilance: 12
Canada Vigilance
US FAERS
65White blood cell count decreasedFAERS: 149
Canada Vigilance: 2
Canada Vigilance
US FAERS
66StomatitisFAERS: 148
Canada Vigilance: 6
Canada Vigilance
US FAERS
67DiverticulitisFAERS: 143
Canada Vigilance: 5
Canada Vigilance
US FAERS
68Drug effective for unapproved indicationFAERS: 140
Canada Vigilance: 1
Canada Vigilance
US FAERS
69CataractFAERS: 139
Canada Vigilance: 7
Canada Vigilance
US FAERS
70Gait inabilityFAERS: 137
Canada Vigilance: 2
Canada Vigilance
US FAERS
71Sensitivity to weather changeFAERS: 137
Canada Vigilance: 39
Canada Vigilance
US FAERS
72UrticariaFAERS: 134
Canada Vigilance: 6
Canada Vigilance
US FAERS
73Limb injuryFAERS: 133
Canada Vigilance: 3
Canada Vigilance
US FAERS
74CellulitisFAERS: 131
Canada Vigilance: 7
Canada Vigilance
US FAERS
75DysphoniaFAERS: 130
Canada Vigilance: 5
Canada Vigilance
US FAERS
76Prescribed overdoseFAERS: 129
Canada Vigilance: 3
Canada Vigilance
US FAERS
77Intentional product use issueFAERS: 128
Canada Vigilance: 13
Canada Vigilance
US FAERS
78TremorFAERS: 125
Canada Vigilance: 4
Canada Vigilance
US FAERS
79Visual ImpairmentFAERS: 125
Canada Vigilance: 6
Canada Vigilance
US FAERS
80PalpitationsFAERS: 122
Canada Vigilance: 6
Canada Vigilance
US FAERS
81PsoriasisFAERS: 120
Canada Vigilance: 2
Canada Vigilance
US FAERS
82AsthmaFAERS: 118
Canada Vigilance: 3
Canada Vigilance
US FAERS
83Joint injuryFAERS: 113US FAERS
84StressFAERS: 113
Canada Vigilance: 5
Canada Vigilance
US FAERS
85ThrombosisFAERS: 113
Canada Vigilance: 4
Canada Vigilance
US FAERS
86FlatulenceFAERS: 111
Canada Vigilance: 9
Canada Vigilance
US FAERS
87Tooth InfectionFAERS: 111
Canada Vigilance: 8
Canada Vigilance
US FAERS
88Skin lesionFAERS: 110
Canada Vigilance: 7
Canada Vigilance
US FAERS
89Therapeutic product effect incompleteFAERS: 110
Canada Vigilance: 324
Canada Vigilance
US FAERS
90Mycobacterium tuberculosis complex test positiveFAERS: 109
Canada Vigilance: 1
Canada Vigilance
US FAERS
91SepsisFAERS: 107
Canada Vigilance: 5
Canada Vigilance
US FAERS
92Limb discomfortFAERS: 106
Canada Vigilance: 3
Canada Vigilance
US FAERS
93NephrolithiasisFAERS: 106
Canada Vigilance: 4
Canada Vigilance
US FAERS
94Disease recurrenceFAERS: 105
Canada Vigilance: 10
Canada Vigilance
US FAERS
95Productive CoughFAERS: 104
Canada Vigilance: 11
Canada Vigilance
US FAERS
96FibromyalgiaFAERS: 103
Canada Vigilance: 6
Canada Vigilance
US FAERS
97EpistaxisFAERS: 101
Canada Vigilance: 3
Canada Vigilance
US FAERS
98Lower respiratory tract infectionFAERS: 99
Canada Vigilance: 40
Canada Vigilance
US FAERS
99Musculoskeletal discomfortFAERS: 99
Canada Vigilance: 3
Canada Vigilance
US FAERS
100NoduleFAERS: 98
Canada Vigilance: 7
Canada Vigilance
US FAERS
101Burning sensationFAERS: 96
Canada Vigilance: 6
Canada Vigilance
US FAERS
102Blood glucose increasedFAERS: 88
Canada Vigilance: 4
Canada Vigilance
US FAERS
103DehydrationFAERS: 88
Canada Vigilance: 6
Canada Vigilance
US FAERS
104Diabetes MellitusFAERS: 88
Canada Vigilance: 5
Canada Vigilance
US FAERS
105Night sweatsFAERS: 88
Canada Vigilance: 9
Canada Vigilance
US FAERS
106Throat irritationFAERS: 88US FAERS
107Dry skinFAERS: 86
Canada Vigilance: 5
Canada Vigilance
US FAERS
108TuberculosisFAERS: 86US FAERS
109TinnitusFAERS: 84
Canada Vigilance: 3
Canada Vigilance
US FAERS
110Chest discomfortFAERS: 83
Canada Vigilance: 5
Canada Vigilance
US FAERS
111Grip strength decreasedFAERS: 82
Canada Vigilance: 1
Canada Vigilance
US FAERS
112LaryngitisFAERS: 82
Canada Vigilance: 5
Canada Vigilance
US FAERS
113Viral upper respiratory tract infectionFAERS: 82
Canada Vigilance: 3
Canada Vigilance
US FAERS
114Bone painFAERS: 81
Canada Vigilance: 5
Canada Vigilance
US FAERS
115DysuriaFAERS: 75
Canada Vigilance: 2
Canada Vigilance
US FAERS
116AmnesiaFAERS: 72US FAERS
117Atrial FibrillationFAERS: 72
Canada Vigilance: 3
Canada Vigilance
US FAERS
118Activities of daily living impairedFAERS: 71US FAERS
119Respiratory tract congestionFAERS: 71
Canada Vigilance: 6
Canada Vigilance
US FAERS
120Pulmonary EmbolismFAERS: 70
Canada Vigilance: 3
Canada Vigilance
US FAERS
121Drug effect delayedFAERS: 68US FAERS
122Eye InfectionFAERS: 64
Canada Vigilance: 2
Canada Vigilance
US FAERS
123WheezingFAERS: 64
Canada Vigilance: 4
Canada Vigilance
US FAERS
124Depressed moodFAERS: 62
Canada Vigilance: 4
Canada Vigilance
US FAERS
125No adverse eventFAERS: 62
Canada Vigilance: 1
Canada Vigilance
US FAERS
126Blood creatinine increasedFAERS: 60US FAERS
127DiscomfortFAERS: 60
Canada Vigilance: 3
Canada Vigilance
US FAERS
128Increased tendency to bruiseFAERS: 60
Canada Vigilance: 1
Canada Vigilance
US FAERS
129VertigoFAERS: 60
Canada Vigilance: 4
Canada Vigilance
US FAERS
130OsteomyelitisFAERS: 59US FAERS
131FractureFAERS: 57
Canada Vigilance: 1
Canada Vigilance
US FAERS
132LethargyFAERS: 57
Canada Vigilance: 1
Canada Vigilance
US FAERS
133Blood triglycerides increasedFAERS: 56US FAERS
134SneezingFAERS: 56
Canada Vigilance: 4
Canada Vigilance
US FAERS
135Carpal Tunnel SyndromeFAERS: 55
Canada Vigilance: 5
Canada Vigilance
US FAERS
136OsteoporosisFAERS: 55
Canada Vigilance: 6
Canada Vigilance
US FAERS
137LymphadenopathyFAERS: 54
Canada Vigilance: 4
Canada Vigilance
US FAERS
138AbasiaFAERS: 53US FAERS
139Back disorderFAERS: 53
Canada Vigilance: 1
Canada Vigilance
US FAERS
140NeuralgiaFAERS: 53
Canada Vigilance: 2
Canada Vigilance
US FAERS
141BlindnessFAERS: 52
Canada Vigilance: 1
Canada Vigilance
US FAERS
142AphoniaFAERS: 51
Canada Vigilance: 6
Canada Vigilance
US FAERS
143DeafnessFAERS: 50US FAERS
144Decreased immune responsivenessFAERS: 50US FAERS
145Low density lipoprotein increasedFAERS: 50US FAERS
146Poor quality sleepFAERS: 50
Canada Vigilance: 5
Canada Vigilance
US FAERS
147DementiaFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
148HypotensionFAERS: 49
Canada Vigilance: 2
Canada Vigilance
US FAERS
149Oral painFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
150PharyngitisFAERS: 49
Canada Vigilance: 5
Canada Vigilance
US FAERS
151UlcerFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
152NervousnessFAERS: 47
Canada Vigilance: 2
Canada Vigilance
US FAERS
153Ankle FractureFAERS: 46US FAERS
154Wrong technique in product usage processFAERS: 46
Canada Vigilance: 3
Canada Vigilance
US FAERS
155HerniaFAERS: 45
Canada Vigilance: 1
Canada Vigilance
US FAERS
156Intentional dose omissionFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
157GastritisFAERS: 44
Canada Vigilance: 2
Canada Vigilance
US FAERS
158PancreatitisFAERS: 44
Canada Vigilance: 4
Canada Vigilance
US FAERS
159SciaticaFAERS: 44
Canada Vigilance: 7
Canada Vigilance
US FAERS
160BursitisFAERS: 43
Canada Vigilance: 2
Canada Vigilance
US FAERS
161OverdoseFAERS: 43US FAERS
162treatment failureFAERS: 43
Canada Vigilance: 7
Canada Vigilance
US FAERS
163Eye painFAERS: 42
Canada Vigilance: 4
Canada Vigilance
US FAERS
164Gastric ulcerFAERS: 42US FAERS
165Musculoskeletal chest painFAERS: 42
Canada Vigilance: 3
Canada Vigilance
US FAERS
166Rash erythematousFAERS: 42
Canada Vigilance: 2
Canada Vigilance
US FAERS
167Blood potassium decreasedFAERS: 41US FAERS
168LacerationFAERS: 41US FAERS
169Rotator cuff syndromeFAERS: 41US FAERS
170Sjogren's SyndromeFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
171DysgeusiaFAERS: 40US FAERS
172Skin UlcerFAERS: 40
Canada Vigilance: 4
Canada Vigilance
US FAERS
173GoutFAERS: 39
Canada Vigilance: 3
Canada Vigilance
US FAERS
174Incorrect dose administeredFAERS: 39
Canada Vigilance: 4
Canada Vigilance
US FAERS
175ToothacheFAERS: 39
Canada Vigilance: 5
Canada Vigilance
US FAERS
176TachycardiaFAERS: 38
Canada Vigilance: 2
Canada Vigilance
US FAERS
177Lip swellingFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
178Irritable Bowel SyndromeFAERS: 36
Canada Vigilance: 3
Canada Vigilance
US FAERS
179Middle insomniaFAERS: 36
Canada Vigilance: 3
Canada Vigilance
US FAERS
180SyncopeFAERS: 36
Canada Vigilance: 3
Canada Vigilance
US FAERS
181Wound InfectionFAERS: 36
Canada Vigilance: 2
Canada Vigilance
US FAERS
182CystFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
183Muscle tightnessFAERS: 35
Canada Vigilance: 2
Canada Vigilance
US FAERS
184ColitisFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
185Disease ProgressionFAERS: 34
Canada Vigilance: 5
Canada Vigilance
US FAERS
186GastroenteritisFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
187Inflammatory marker increasedFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
188Nodal osteoarthritisFAERS: 34US FAERS
189Urinary IncontinenceFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
190Alanine Aminotransferase IncreasedFAERS: 33US FAERS
191Pulmonary congestionFAERS: 33
Canada Vigilance: 3
Canada Vigilance
US FAERS
192Feeling ColdFAERS: 32
Canada Vigilance: 4
Canada Vigilance
US FAERS
193LymphomaFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
194furuncleFAERS: 32US FAERS
195Clostridium difficile infectionFAERS: 31
Canada Vigilance: 3
Canada Vigilance
US FAERS
196OnychomycosisFAERS: 31US FAERS
197Paranasal sinus discomfortFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
198Pulmonary FibrosisFAERS: 31
Canada Vigilance: 4
Canada Vigilance
US FAERS
199Synovial CystFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
200Upper respiratory tract congestionFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
201CholelithiasisFAERS: 30US FAERS
202ChromaturiaFAERS: 30
Canada Vigilance: 3
Canada Vigilance
US FAERS
203Ear discomfortFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
204HypokinesiaFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
205ImmunosuppressionFAERS: 30US FAERS
206Joint warmthFAERS: 30US FAERS
207Aspartate Aminotransferase IncreasedFAERS: 29US FAERS
208EczemaFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
209Eye irritationFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
210Gastrointestinal perforationFAERS: 29US FAERS
211Sinus headacheFAERS: 29US FAERS
212Deep Vein ThrombosisFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
213Inappropriate schedule of drug administrationFAERS: 28US FAERS
214Intestinal ObstructionFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
215BedriddenFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
216Blood glucose decreasedFAERS: 27US FAERS
217Food PoisoningFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
218Muscle strainFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
219Pulmonary thrombosisFAERS: 27US FAERS
220Renal painFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
221Secretion dischargeFAERS: 27
Canada Vigilance: 3
Canada Vigilance
US FAERS
222Blood count abnormalFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
223Blood iron decreasedFAERS: 25
Canada Vigilance: 3
Canada Vigilance
US FAERS
224Blood urine presentFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
225FlushingFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
226Oral candidiasisFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
227Post procedural complicationFAERS: 25
Canada Vigilance: 4
Canada Vigilance
US FAERS
228Upper-airway cough syndromeFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
229Blood creatine phosphokinase increasedFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
230Head discomfortFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
231Meniscus injuryFAERS: 24US FAERS
232Post procedural infectionFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
233Rheumatoid NoduleFAERS: 24US FAERS
234Temperature intoleranceFAERS: 24US FAERS
235ThirstFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
236AppendicitisFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
237Bowel movement irregularityFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
238Escherichia infectionFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
239GlaucomaFAERS: 23US FAERS
240HypersomniaFAERS: 23
Canada Vigilance: 3
Canada Vigilance
US FAERS
241Oral infectionFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
242Soft tissue swellingFAERS: 23US FAERS
243Ligament ruptureFAERS: 22
Canada Vigilance: 3
Canada Vigilance
US FAERS
244Nasal discomfortFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
245NocturiaFAERS: 22US FAERS
246OnychoclasisFAERS: 22
Canada Vigilance: 2
Canada Vigilance
US FAERS
247Paranasal sinus hypersecretionFAERS: 22US FAERS
248CryingFAERS: 21US FAERS
249DiverticulumFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
250Gastrointestinal PainFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
251Large intestine perforationFAERS: 21US FAERS
252AbscessFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
253Acute kidney injuryFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
254Arthropod biteFAERS: 20US FAERS
255Bone erosionFAERS: 20US FAERS
256Clostridium difficile colitisFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
257ConjunctivitisFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
258Expired product administeredFAERS: 20US FAERS
259General physical health deteriorationFAERS: 20US FAERS
260Mood swingsFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
261Accidental overdoseFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
262AgitationFAERS: 19US FAERS
263Basal cell carcinomaFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
264Feeling jitteryFAERS: 19US FAERS
265Hepatitis B virus test positiveFAERS: 19US FAERS
266Medication residue presentFAERS: 19US FAERS
267Product residue presentFAERS: 19US FAERS
268RestlessnessFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
269Spinal column stenosisFAERS: 19US FAERS
270nervous system disorderFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
271Blood pressure fluctuationFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
272Cardiac ArrestFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
273ChokingFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
274Device related infectionFAERS: 18US FAERS
275Emotional disorderFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
276EructationFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
277FolliculitisFAERS: 18US FAERS
278Gastric infectionFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
279HordeolumFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
280HungerFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
281Intervertebral Disc DegenerationFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
282LeukopeniaFAERS: 18US FAERS
283Pain of skinFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
284Respiratory FailureFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
285RosaceaFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
286Squamous cell carcinomaFAERS: 18US FAERS
287VasculitisFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
288Aortic AneurysmFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
289Cold sweatFAERS: 17US FAERS
290Drug prescribing errorFAERS: 17US FAERS
291Facial PainFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
292Hepatitis CFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
293HepatitisFAERS: 17US FAERS
294Intestinal PerforationFAERS: 17US FAERS
295Latent TuberculosisFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
296Macular degenerationFAERS: 17US FAERS
297PleurisyFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
298Unevaluable eventFAERS: 17US FAERS
299AgeusiaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
300Angina PectorisFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
301Chronic sinusitisFAERS: 16US FAERS
302DermatitisFAERS: 16US FAERS
303DysgraphiaFAERS: 16US FAERS
304Facial paralysisFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
305Flank PainFAERS: 16US FAERS
306Full blood count decreasedFAERS: 16US FAERS
307GingivitisFAERS: 16
Canada Vigilance: 4
Canada Vigilance
US FAERS
308NeutropeniaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
309Restless Legs SyndromeFAERS: 16US FAERS
310Skin PapillomaFAERS: 16US FAERS
311Skin lacerationFAERS: 16
Canada Vigilance: 3
Canada Vigilance
US FAERS
312ThrombocytopeniaFAERS: 16US FAERS
313skin abrasionFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
314DeformityFAERS: 15US FAERS
315DisorientationFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
316Drug administered to patient of inappropriate ageFAERS: 15US FAERS
317EcchymosisFAERS: 15US FAERS
318Hepatitis BFAERS: 15US FAERS
319High density lipoprotein increasedFAERS: 14US FAERS
320Initial insomniaFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
321Multiple SclerosisFAERS: 14US FAERS
322Nerve injuryFAERS: 14US FAERS
323ObesityFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
324ScabFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
325Subcutaneous AbscessFAERS: 14US FAERS
326Urinary RetentionFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
327Atrioventricular BlockFAERS: 13US FAERS
328Blood alkaline phosphatase increasedFAERS: 13US FAERS
329Circumstance or information capable of leading to medication errorFAERS: 13US FAERS
330Gastrointestinal sounds abnormalFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
331Impaired work abilityFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
332Infectious colitisFAERS: 13US FAERS
333Ocular discomfortFAERS: 13US FAERS
334Sinus painFAERS: 13
Canada Vigilance: 4
Canada Vigilance
US FAERS
335Tongue discomfortFAERS: 13US FAERS
336VitiligoFAERS: 13US FAERS
337Vulvovaginal mycotic infectionFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
338Acute myocardial infarctionFAERS: 12US FAERS
339Blood cholesterol abnormalFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
340Bone swellingFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
341Breakthrough PainFAERS: 12US FAERS
342DiplopiaFAERS: 12US FAERS
343Drug dispensing errorFAERS: 12US FAERS
344Extra dose administeredFAERS: 12US FAERS
345Eye inflammationFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
346Hypertensive crisisFAERS: 12US FAERS
347Impaired driving abilityFAERS: 12US FAERS
348MeningitisFAERS: 12US FAERS
349PericarditisFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
350Skin irritationFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
351Therapeutic product effect decreasedFAERS: 12
Canada Vigilance: 14
Canada Vigilance
US FAERS
352Thermal burnFAERS: 12US FAERS
353Transaminases increasedFAERS: 12US FAERS
354AphasiaFAERS: 11US FAERS
355Atypical pneumoniaFAERS: 11US FAERS
356Blood creatine increasedFAERS: 11US FAERS
357Blood glucose abnormalFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
358Blood sodium decreasedFAERS: 11US FAERS
359CheilitisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
360Dental cariesFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
361HepatomegalyFAERS: 11US FAERS
362Intervertebral disc disorderFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
363OsteopeniaFAERS: 11US FAERS
364PancytopeniaFAERS: 11US FAERS
365Pericardial effusionFAERS: 11US FAERS
366Prescribed underdoseFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
367Rheumatoid factor increasedFAERS: 11US FAERS
368Root canal infectionFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
369TenosynovitisFAERS: 11US FAERS
370Therapy non-responderFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
371TonsillitisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
372Tooth ExtractionFAERS: 11US FAERS
373Uterine CancerFAERS: 11US FAERS
374Antibiotic therapyFAERS: 10US FAERS
375Emotional distressFAERS: 10US FAERS
376Enzyme level increasedFAERS: 10US FAERS
377Genital rashFAERS: 10US FAERS
378HyperchlorhydriaFAERS: 10US FAERS
379MenorrhagiaFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
380Multiple allergiesFAERS: 10US FAERS
381Nail InfectionFAERS: 10US FAERS
382Pancreatic carcinomaFAERS: 10US FAERS
383Pelvic PainFAERS: 10US FAERS
384PhotophobiaFAERS: 10US FAERS
385PolyuriaFAERS: 10US FAERS
386PresyncopeFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
387Product prescribing errorFAERS: 10US FAERS
388Tooth LossFAERS: 10US FAERS
389TrichorrhexisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
390Alopecia AreataFAERS: 9US FAERS
391AngerFAERS: 9US FAERS
392AngioedemaFAERS: 9US FAERS
393Bone density decreasedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
394BronchiectasisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
395Cardiac FlutterFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
396Cartilage injuryFAERS: 9US FAERS
397Cerebral disorderFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
398Drug effect variableFAERS: 9US FAERS
399Epigastric discomfortFAERS: 9US FAERS
400Feeling of body temperature changeFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
401Gastrointestinal viral infectionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
402Incorrect route of product administrationFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
403Increased upper airway secretionFAERS: 9US FAERS
404Infected cystFAERS: 9US FAERS
405Lyme DiseaseFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
406Lymphocyte count decreasedFAERS: 9US FAERS
407Mental impairmentFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
408Poor quality drug administeredFAERS: 9US FAERS
409Product administration errorFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
410Product storage errorFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
411Pulmonary painFAERS: 9US FAERS
412RalesFAERS: 9US FAERS
413Retinal DetachmentFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
414Squamous cell carcinoma of skinFAERS: 9US FAERS
415SunburnFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
416Tension HeadacheFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
417White blood cell count abnormalFAERS: 9US FAERS
418muscle injuryFAERS: 9US FAERS
419Acute respiratory failureFAERS: 8US FAERS
420AneurysmFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
421Blood potassium abnormalFAERS: 8US FAERS
422BradycardiaFAERS: 8US FAERS
423Butterfly rashFAERS: 8US FAERS
424Cataract operationFAERS: 8US FAERS
425Contraindicated product administeredFAERS: 8US FAERS
426Diverticular perforationFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
427Drug administration errorFAERS: 8US FAERS
428DysarthriaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
429Erectile dysfunctionFAERS: 8US FAERS
430Food AllergyFAERS: 8US FAERS
431HyperkeratosisFAERS: 8US FAERS
432InfarctionFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
433LymphopeniaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
434Medication ErrorFAERS: 8US FAERS
435Oropharyngeal discomfortFAERS: 8US FAERS
436Pleuritic painFAERS: 8US FAERS
437PneumothoraxFAERS: 8US FAERS
438SluggishnessFAERS: 8US FAERS
439Therapeutic response changedFAERS: 8US FAERS
440Vulvovaginal pruritusFAERS: 8US FAERS
441Adverse eventFAERS: 7US FAERS
442Bipolar DisorderFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
443Bladder painFAERS: 7US FAERS
444BronchospasmFAERS: 7US FAERS
445DeliriumFAERS: 7US FAERS
446DyslexiaFAERS: 7US FAERS
447EncephalitisFAERS: 7US FAERS
448Eye ulcerFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
449FormicationFAERS: 7US FAERS
450Frustration tolerance decreasedFAERS: 7US FAERS
451Gastrointestinal motility disorderFAERS: 7US FAERS
452HepatotoxicityFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
453HypertrophyFAERS: 7US FAERS
454HypoxiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
455HysterectomyFAERS: 7US FAERS
456Impaired gastric emptyingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
457Infectious MononucleosisFAERS: 7US FAERS
458Intracranial AneurysmFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
459Joint InstabilityFAERS: 7US FAERS
460Joint abscessFAERS: 7US FAERS
461Limb massFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
462MastitisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
463MenopauseFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
464Mouth swellingFAERS: 7US FAERS
465MyelitisFAERS: 7US FAERS
466MyositisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
467Neutrophil count decreasedFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
468Noninfective gingivitisFAERS: 7US FAERS
469Oral fungal infectionFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
470Oral mucosal eruptionFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
471PapuleFAERS: 7US FAERS
472Pathogen resistanceFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
473PhlebitisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
474PneumonitisFAERS: 7US FAERS
475Poor quality product administeredFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
476Precancerous skin lesionFAERS: 7US FAERS
477Product dispensing errorFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
478Psychiatric symptomFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
479Respiratory arrestFAERS: 7US FAERS
480RetchingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
481RhabdomyolysisFAERS: 7US FAERS
482Rheumatic disorderFAERS: 7US FAERS
483RhinalgiaFAERS: 7US FAERS
484RhinitisFAERS: 7US FAERS
485Therapy changeFAERS: 7US FAERS
486Tongue blisteringFAERS: 7US FAERS
487Tympanic Membrane PerforationFAERS: 7US FAERS
488Umbilical herniaFAERS: 7US FAERS
489Urinary bladder polypFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
490Wrist deformityFAERS: 7US FAERS
491effusionFAERS: 7US FAERS
492Abdominal InfectionFAERS: 6US FAERS
493Animal biteFAERS: 6US FAERS
494Ankylosing spondylitisFAERS: 6US FAERS
495ApathyFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
496Autoimmune thyroiditisFAERS: 6US FAERS
497Blood creatinine abnormalFAERS: 6US FAERS
498Blood potassium increasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
499CardiomegalyFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
500Compression fractureFAERS: 6US FAERS
501CyanosisFAERS: 6US FAERS
502Dermatitis acneiformFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
503EmbolismFAERS: 6US FAERS
504Extremity contractureFAERS: 6US FAERS
505Gastrointestinal infectionFAERS: 6US FAERS
506General physical condition abnormalFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
507Genital discomfortFAERS: 6US FAERS
508HemiplegiaFAERS: 6US FAERS
509HidradenitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
510HyperthyroidismFAERS: 6US FAERS
511Infected biteFAERS: 6US FAERS
512LabyrinthitisFAERS: 6US FAERS
513LeukocytosisFAERS: 6US FAERS
514LipomaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
515Liver AbscessFAERS: 6US FAERS
516Lymphocyte count abnormalFAERS: 6US FAERS
517Lymphocyte count increasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
518MalabsorptionFAERS: 6US FAERS
519Mental status changesFAERS: 6US FAERS
520MetatarsalgiaFAERS: 6US FAERS
521Migraine with AuraFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
522Occult blood positiveFAERS: 6US FAERS
523Optic NeuritisFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
524OverweightFAERS: 6US FAERS
525Peptic UlcerFAERS: 6US FAERS
526PeriarthritisFAERS: 6US FAERS
527PeritonitisFAERS: 6US FAERS
528Peritonsillar AbscessFAERS: 6US FAERS
529Poor peripheral circulationFAERS: 6US FAERS
530Post-traumatic neck syndromeFAERS: 6US FAERS
531Pulmonary HypertensionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
532Respiratory distressFAERS: 6US FAERS
533Respiratory tract infection viralFAERS: 6US FAERS
534Skin reactionFAERS: 6US FAERS
535SpondylitisFAERS: 6US FAERS
536Therapeutic product effect delayedFAERS: 6
Canada Vigilance: 28
Canada Vigilance
US FAERS
537Tinea PedisFAERS: 6US FAERS
538Vitamin D DeficiencyFAERS: 6US FAERS
539Vitreous floatersFAERS: 6US FAERS
540Walking aid userFAERS: 6US FAERS
541Apparent deathFAERS: 5US FAERS
542ArthrodesisFAERS: 5US FAERS
543AsphyxiaFAERS: 5US FAERS
544Blood creatinine decreasedFAERS: 5US FAERS
545Blood magnesium decreasedFAERS: 5US FAERS
546Bone fissureFAERS: 5US FAERS
547C-reactive protein abnormalFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
548Cerebral InfarctionFAERS: 5US FAERS
549Cholecystitis infectiveFAERS: 5US FAERS
550CholecystitisFAERS: 5US FAERS
551CoccidioidomycosisFAERS: 5US FAERS
552DemyelinationFAERS: 5US FAERS
553DermatomyositisFAERS: 5US FAERS
554Device dislocationFAERS: 5US FAERS
555Diabetes mellitus inadequate controlFAERS: 5US FAERS
556Ear congestionFAERS: 5US FAERS
557EnteritisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
558EpilepsyFAERS: 5US FAERS
559ErysipelasFAERS: 5US FAERS
560Full blood count abnormalFAERS: 5US FAERS
561HistoplasmosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
562HyperphagiaFAERS: 5US FAERS
563Impaired quality of lifeFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
564Inappropriate schedule of product administrationFAERS: 5
Canada Vigilance: 5
Canada Vigilance
US FAERS
565IncontinenceFAERS: 5US FAERS
566Intervertebral disc injuryFAERS: 5US FAERS
567Ligament painFAERS: 5US FAERS
568Low density lipoprotein abnormalFAERS: 5US FAERS
569LymphadenitisFAERS: 5US FAERS
570Maternal exposure during pregnancyFAERS: 5US FAERS
571OnycholysisFAERS: 5US FAERS
572Oropharyngeal blisteringFAERS: 5US FAERS
573PallorFAERS: 5US FAERS
574Pelvic massFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
575Peripheral arterial occlusive diseaseFAERS: 5US FAERS
576Pharyngeal swellingFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
577Physical disabilityFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
578PolyarthritisFAERS: 5US FAERS
579Postoperative wound complicationFAERS: 5US FAERS
580Rectal abscessFAERS: 5US FAERS
581Rehabilitation therapyFAERS: 5US FAERS
582Renal cystFAERS: 5US FAERS
583Retinitis PigmentosaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
584SclerodermaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
585Tongue pruritusFAERS: 5US FAERS
586Unresponsive to stimuliFAERS: 5US FAERS
587Vaginal DischargeFAERS: 5US FAERS
588Vaginal abscessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
589Wheelchair userFAERS: 5US FAERS
590AcarodermatitisFAERS: 4US FAERS
591Alanine aminotransferase decreasedFAERS: 4US FAERS
592Allergic sinusitisFAERS: 4US FAERS
593Anaphylactic shockFAERS: 4US FAERS
594Animal scratchFAERS: 4US FAERS
595Anorectal discomfortFAERS: 4US FAERS
596AnosmiaFAERS: 4US FAERS
597Anti-cyclic citrullinated peptide antibody positiveFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
598Arthropod stingFAERS: 4US FAERS
599Bacterial sepsisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
600Biliary ColicFAERS: 4US FAERS
601BlepharitisFAERS: 4US FAERS
602Bone contusionFAERS: 4US FAERS
603Bone density abnormalFAERS: 4US FAERS
604Brain AbscessFAERS: 4US FAERS
605Carbon dioxide decreasedFAERS: 4US FAERS
606Cervix carcinomaFAERS: 4US FAERS
607Complication associated with deviceFAERS: 4US FAERS
608Device looseningFAERS: 4US FAERS
609DisabilityFAERS: 4US FAERS
610EnuresisFAERS: 4US FAERS
611Excessive cerumen productionFAERS: 4US FAERS
612Fluid overloadFAERS: 4US FAERS
613Food cravingFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
614GlossitisFAERS: 4US FAERS
615GranulomaFAERS: 4US FAERS
616HemiparesisFAERS: 4US FAERS
617Hepatitis C antibody positiveFAERS: 4US FAERS
618HypertrichosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
619HypothyroidismFAERS: 4US FAERS
620Idiopathic Pulmonary FibrosisFAERS: 4US FAERS
621IncoherentFAERS: 4US FAERS
622Increased viscosity of bronchial secretionFAERS: 4US FAERS
623Increased viscosity of upper respiratory secretionFAERS: 4US FAERS
624Intervertebral disc compressionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
625IritisFAERS: 4US FAERS
626KeratitisFAERS: 4US FAERS
627Limb operationFAERS: 4US FAERS
628Loose toothFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
629Lupus-like syndromeFAERS: 4US FAERS
630MeningiomaFAERS: 4US FAERS
631Myasthenia GravisFAERS: 4US FAERS
632MydriasisFAERS: 4US FAERS
633NeuromaFAERS: 4US FAERS
634OliguriaFAERS: 4US FAERS
635Pancreatic CystFAERS: 4US FAERS
636Peripheral venous diseaseFAERS: 4US FAERS
637PertussisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
638PolyneuropathyFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
639Prescription drug used without a prescriptionFAERS: 4US FAERS
640Product label issueFAERS: 4US FAERS
641Product quality issueFAERS: 4US FAERS
642Product solubility abnormalFAERS: 4US FAERS
643Product use complaintFAERS: 4US FAERS
644PurpuraFAERS: 4US FAERS
645Radicular painFAERS: 4US FAERS
646RegurgitationFAERS: 4US FAERS
647Septic ShockFAERS: 4US FAERS
648Skin hypertrophyFAERS: 4US FAERS
649Skin tightnessFAERS: 4US FAERS
650Sleep disorder due to general medical condition, insomnia typeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
651SnoringFAERS: 4US FAERS
652Soft Tissue InfectionFAERS: 4US FAERS
653SternitisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
654Streptococcus test positiveFAERS: 4US FAERS
655Stress at workFAERS: 4US FAERS
656Throat cancerFAERS: 4US FAERS
657ThrombophlebitisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
658Trigeminal NeuralgiaFAERS: 4US FAERS
659Urinary Tract PainFAERS: 4US FAERS
660UveitisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
661Vulvovaginal drynessFAERS: 4US FAERS
662jaundiceFAERS: 4US FAERS
663kyphosisFAERS: 4US FAERS
664prostatitisFAERS: 4US FAERS
665Abdominal adhesionsFAERS: 3US FAERS
666Abdominal symptomFAERS: 3US FAERS
667Abdominal tendernessFAERS: 3US FAERS
668Abdominal wall cystFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
669Alopecia totalisFAERS: 3US FAERS
670Alopecia universalisFAERS: 3US FAERS
671Anal abscessFAERS: 3US FAERS
672Ankle deformityFAERS: 3US FAERS
673AphagiaFAERS: 3US FAERS
674Aphthous StomatitisFAERS: 3US FAERS
675ArteriosclerosisFAERS: 3US FAERS
676Autoimmune hepatitisFAERS: 3US FAERS
677Autonomic nervous system imbalanceFAERS: 3US FAERS
678Bacterial VaginosisFAERS: 3US FAERS
679BlepharospasmFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
680Blood albumin abnormalFAERS: 3US FAERS
681Blood glucose fluctuationFAERS: 3US FAERS
682Blood immunoglobulin G decreasedFAERS: 3US FAERS
683Blood lactate dehydrogenase increasedFAERS: 3US FAERS
684Blood sodium increasedFAERS: 3US FAERS
685Blood urea increasedFAERS: 3US FAERS
686Bowen's DiseaseFAERS: 3US FAERS
687Bronchial HyperreactivityFAERS: 3US FAERS
688Burn infectionFAERS: 3US FAERS
689Carcinoembryonic antigen increasedFAERS: 3US FAERS
690Carotid artery occlusionFAERS: 3US FAERS
691CatarrhFAERS: 3US FAERS
692Cerebral cystFAERS: 3US FAERS
693Choking sensationFAERS: 3US FAERS
694CholestasisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
695Coating in mouthFAERS: 3US FAERS
696Completed SuicideFAERS: 3US FAERS
697Coronary Artery DiseaseFAERS: 3US FAERS
698CytopeniaFAERS: 3US FAERS
699Dengue FeverFAERS: 3US FAERS
700Diabetic KetoacidosisFAERS: 3US FAERS
701Diabetic ulcerFAERS: 3US FAERS
702Disseminated Intravascular CoagulationFAERS: 3US FAERS
703Drug withdrawal syndromeFAERS: 3US FAERS
704Embolic strokeFAERS: 3US FAERS
705EndocarditisFAERS: 3US FAERS
706EnthesopathyFAERS: 3US FAERS
707EpididymitisFAERS: 3US FAERS
708Essential HypertensionFAERS: 3US FAERS
709Essential TremorFAERS: 3US FAERS
710ExcoriationFAERS: 3US FAERS
711Extremity necrosisFAERS: 3US FAERS
712Eyelid Function DisorderFAERS: 3US FAERS
713FibrosisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
714Foreign body sensation in eyesFAERS: 3US FAERS
715Gastric hypermotilityFAERS: 3US FAERS
716Gastrointestinal obstructionFAERS: 3US FAERS
717Gastrointestinal ulcerFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
718Groin infectionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
719Guillain-Barre SyndromeFAERS: 3US FAERS
720Heart sounds abnormalFAERS: 3US FAERS
721Heat ExhaustionFAERS: 3US FAERS
722Hip surgeryFAERS: 3US FAERS
723HydrocephalusFAERS: 3US FAERS
724HydronephrosisFAERS: 3US FAERS
725HyperventilationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
726Immunoglobulins abnormalFAERS: 3US FAERS
727Incorrect product storageFAERS: 3US FAERS
728Insurance issueFAERS: 3US FAERS
729Intercepted medication errorFAERS: 3US FAERS
730Invasive Ductal Breast CarcinomaFAERS: 3US FAERS
731Iron deficiencyFAERS: 3US FAERS
732Irregular breathingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
733Joint destructionFAERS: 3US FAERS
734Ligament injuryFAERS: 3US FAERS
735Lipids abnormalFAERS: 3US FAERS
736Lower respiratory tract infection bacterialFAERS: 3US FAERS
737Lung AbscessFAERS: 3US FAERS
738MYELODYSPLASTIC SYNDROMEFAERS: 3US FAERS
739MaculeFAERS: 3US FAERS
740MonoplegiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
741Motion SicknessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
742MutismFAERS: 3US FAERS
743Mycobacterium test positiveFAERS: 3US FAERS
744NephritisFAERS: 3US FAERS
745Neutrophil count abnormalFAERS: 3US FAERS
746Ocular vascular disorderFAERS: 3US FAERS
747Oropharyngeal candidiasisFAERS: 3US FAERS
748OsteitisFAERS: 3US FAERS
749ParotitisFAERS: 3US FAERS
750Peripheral artery thrombosisFAERS: 3US FAERS
751Pneumococcal sepsisFAERS: 3US FAERS
752Post-Traumatic Stress DisorderFAERS: 3US FAERS
753Product label confusionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
754Product taste abnormalFAERS: 3US FAERS
755Protein total abnormalFAERS: 3US FAERS
756Protein total increasedFAERS: 3US FAERS
757ProteinuriaFAERS: 3US FAERS
758Pustular psoriasisFAERS: 3US FAERS
759PyelonephritisFAERS: 3US FAERS
760Quality of life decreasedFAERS: 3US FAERS
761Rhinovirus infectionFAERS: 3US FAERS
762SarcoidosisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
763ScleritisFAERS: 3US FAERS
764ShockFAERS: 3US FAERS
765Skin ErosionFAERS: 3US FAERS
766Spinal column injuryFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
767Splenic neoplasm malignancy unspecifiedFAERS: 3US FAERS
768StenosisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
769Supraventricular tachycardiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
770T-Cell LymphomaFAERS: 3US FAERS
771TYPHUSFAERS: 3US FAERS
772Tender joint count increasedFAERS: 3US FAERS
773TensionFAERS: 3US FAERS
774Thoracic vertebral fractureFAERS: 3US FAERS
775Thyroid NeoplasmFAERS: 3US FAERS
776Toxicity to various agentsFAERS: 3US FAERS
777TracheitisFAERS: 3US FAERS
778Troponin increasedFAERS: 3US FAERS
779Urinary hesitationFAERS: 3US FAERS
780Urine output increasedFAERS: 3US FAERS
781Uterine PolypFAERS: 3US FAERS
782Venous ThrombosisFAERS: 3US FAERS
783Ventricular arrhythmiaFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
784Vocal Cord ParalysisFAERS: 3US FAERS
785Vulvovaginal burning sensationFAERS: 3US FAERS
786Wound infection staphylococcalFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
787Wrong doseFAERS: 3US FAERS
788colonoscopyFAERS: 3US FAERS
789Abdominal AbscessFAERS: 2US FAERS
790Abdominal massFAERS: 2US FAERS
791Actinic keratosisFAERS: 2US FAERS
792AdenocarcinomaFAERS: 2US FAERS
793Alcohol interactionFAERS: 2US FAERS
794Allergy to chemicalsFAERS: 2US FAERS
795Ammonia increasedFAERS: 2US FAERS
796Amyotrophic Lateral SclerosisFAERS: 2US FAERS
797AscitesFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
798Aspartate aminotransferase abnormalFAERS: 2US FAERS
799AsthenopiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
800Atrial FlutterFAERS: 2US FAERS
801Bacterial test positiveFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
802Benign NeoplasmFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
803Bile Duct StenosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
804Bladder malposition acquiredFAERS: 2US FAERS
805Blood albumin decreasedFAERS: 2US FAERS
806Blood chloride decreasedFAERS: 2US FAERS
807Blood electrolytes abnormalFAERS: 2US FAERS
808Blood immunoglobulin G increasedFAERS: 2US FAERS
809Blood testosterone decreasedFAERS: 2US FAERS
810Blood thyroid stimulating hormone abnormalFAERS: 2US FAERS
811Blood thyroid stimulating hormone increasedFAERS: 2US FAERS
812Blood urea nitrogen/creatinine ratio increasedFAERS: 2US FAERS
813BradyphreniaFAERS: 2US FAERS
814Brain natriuretic peptide increasedFAERS: 2US FAERS
815Breast CystFAERS: 2US FAERS
816Breast tendernessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
817BronchiolitisFAERS: 2US FAERS
818BruxismFAERS: 2US FAERS
819C-reactive protein decreasedFAERS: 2US FAERS
820CalcinosisFAERS: 2US FAERS
821Cardiac procedure complicationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
822Cardiac ventricular disorderFAERS: 2US FAERS
823Cauda Equina SyndromeFAERS: 2US FAERS
824Cerebral ThrombosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
825ClumsinessFAERS: 2US FAERS
826Complication of device insertionFAERS: 2US FAERS
827Cytomegalovirus chorioretinitisFAERS: 2US FAERS
828Dark circles under eyesFAERS: 2US FAERS
829Decreased vibratory senseFAERS: 2US FAERS
830Dental discomfortFAERS: 2US FAERS
831Depressed Level of ConsciousnessFAERS: 2US FAERS
832Dermatitis HerpetiformisFAERS: 2US FAERS
833Device FailureFAERS: 2US FAERS
834Diabetic FootFAERS: 2US FAERS
835Diabetic NephropathyFAERS: 2US FAERS
836DiplegiaFAERS: 2US FAERS
837Drug DependenceFAERS: 2US FAERS
838Drug ToleranceFAERS: 2US FAERS
839Duodenal UlcerFAERS: 2US FAERS
840Elbow deformityFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
841Electrocardiogram abnormalFAERS: 2US FAERS
842Endometrial adenocarcinomaFAERS: 2US FAERS
843EndometriosisFAERS: 2US FAERS
844Enlarged uvulaFAERS: 2US FAERS
845EnterocolitisFAERS: 2US FAERS
846EpicondylitisFAERS: 2US FAERS
847Escherichia sepsisFAERS: 2US FAERS
848Escherichia urinary tract infectionFAERS: 2US FAERS
849Exfoliative rashFAERS: 2US FAERS
850Exposure via partnerFAERS: 2US FAERS
851Eye symptomFAERS: 2US FAERS
852Eyelid margin crustingFAERS: 2US FAERS
853Febrile NeutropeniaFAERS: 2US FAERS
854Gallbladder painFAERS: 2US FAERS
855Gastric BypassFAERS: 2US FAERS
856Gastroenteritis norovirusFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
857Gastrointestinal inflammationFAERS: 2US FAERS
858General physical condition decreasedFAERS: 2US FAERS
859Genital HerpesFAERS: 2US FAERS
860Genital infection fungalFAERS: 2US FAERS
861Gingival RecessionFAERS: 2US FAERS
862Glioblastoma MultiformeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
863Graft infectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
864Granulocyte count increasedFAERS: 2US FAERS
865Granuloma AnnulareFAERS: 2US FAERS
866Grief reactionFAERS: 2US FAERS
867Hepatic InfectionFAERS: 2US FAERS
868Hepatic enzyme decreasedFAERS: 2US FAERS
869Hernial eventrationFAERS: 2US FAERS
870Hypermobility syndromeFAERS: 2US FAERS
871HypophagiaFAERS: 2US FAERS
872ImmobileFAERS: 2US FAERS
873ImpatienceFAERS: 2US FAERS
874ImpetigoFAERS: 2US FAERS
875Infective aortitisFAERS: 2US FAERS
876Infrequent bowel movementsFAERS: 2US FAERS
877Inguinal massFAERS: 2US FAERS
878Injection Site ReactionFAERS: 2US FAERS
879IntertrigoFAERS: 2US FAERS
880Intestinal FistulaFAERS: 2US FAERS
881Lactose IntoleranceFAERS: 2US FAERS
882Lip and/or oral cavity cancerFAERS: 2US FAERS
883Lip exfoliationFAERS: 2US FAERS
884Lip pruritusFAERS: 2US FAERS
885Lower respiratory tract infection viralFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
886Lung carcinoma cell type unspecified stage IFAERS: 2US FAERS
887Lung herniaFAERS: 2US FAERS
888Lymph Node TuberculosisFAERS: 2US FAERS
889Malignant neoplasm progressionFAERS: 2US FAERS
890Mantle cell lymphomaFAERS: 2US FAERS
891Mastication disorderFAERS: 2US FAERS
892MastoiditisFAERS: 2US FAERS
893Medical device site joint infectionFAERS: 2US FAERS
894Meniscal degenerationFAERS: 2US FAERS
895MetrorrhagiaFAERS: 2US FAERS
896Monocyte count increasedFAERS: 2US FAERS
897Multiple sclerosis relapseFAERS: 2US FAERS
898Muscle RigidityFAERS: 2US FAERS
899Musculoskeletal DeformityFAERS: 2US FAERS
900Mycosis FungoidesFAERS: 2US FAERS
901MyocarditisFAERS: 2US FAERS
902MyoclonusFAERS: 2US FAERS
903MyopiaFAERS: 2US FAERS
904Nail bed disorderFAERS: 2US FAERS
905NeuritisFAERS: 2US FAERS
906Neuroleptic Malignant SyndromeFAERS: 2US FAERS
907Non-cardiac chest painFAERS: 2US FAERS
908Nuchal RigidityFAERS: 2US FAERS
909ObstructionFAERS: 2US FAERS
910OligohydramniosFAERS: 2US FAERS
911Orchitis noninfectiveFAERS: 2US FAERS
912OrchitisFAERS: 2US FAERS
913Panic DisorderFAERS: 2US FAERS
914PanniculitisFAERS: 2US FAERS
915ParaplegiaFAERS: 2US FAERS
916Parasitic gastroenteritisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
917Parotid abscessFAERS: 2US FAERS
918Patellofemoral Pain SyndromeFAERS: 2US FAERS
919Pathological fractureFAERS: 2US FAERS
920Patient-device incompatibilityFAERS: 2US FAERS
921Perihepatic discomfortFAERS: 2US FAERS
922Perineal rashFAERS: 2US FAERS
923PeriodontitisFAERS: 2US FAERS
924Perioral DermatitisFAERS: 2US FAERS
925Personality ChangeFAERS: 2US FAERS
926PetechiaeFAERS: 2US FAERS
927Pharyngeal StenosisFAERS: 2US FAERS
928Physical product label issueFAERS: 2US FAERS
929PiloerectionFAERS: 2US FAERS
930Pilonidal CystFAERS: 2US FAERS
931Platelet count abnormalFAERS: 2US FAERS
932PoisoningFAERS: 2US FAERS
933PolydipsiaFAERS: 2US FAERS
934Portal HypertensionFAERS: 2US FAERS
935Portal Vein ThrombosisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
936Post procedural discomfortFAERS: 2US FAERS
937PouchitisFAERS: 2US FAERS
938Product container issueFAERS: 2US FAERS
939Product packaging issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
940Product shape issueFAERS: 2US FAERS
941Prolonged expirationFAERS: 2US FAERS
942Protein urine presentFAERS: 2US FAERS
943PurulenceFAERS: 2US FAERS
944PyuriaFAERS: 2US FAERS
945Renal Cell CarcinomaFAERS: 2US FAERS
946Retroperitoneal abscessFAERS: 2US FAERS
947Rheumatic FeverFAERS: 2US FAERS
948RhonchiFAERS: 2US FAERS
949SLE arthritisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
950SarcomaFAERS: 2US FAERS
951Sexual DysfunctionFAERS: 2US FAERS
952Single functional kidneyFAERS: 2US FAERS
953SinobronchitisFAERS: 2US FAERS
954Skeletal injuryFAERS: 2US FAERS
955Skin WrinklingFAERS: 2US FAERS
956Sleep TalkingFAERS: 2US FAERS
957Sleep disorder due to a general medical conditionFAERS: 2US FAERS
958Slow speechFAERS: 2US FAERS
959Small intestine carcinomaFAERS: 2US FAERS
960Stevens-Johnson SyndromeFAERS: 2US FAERS
961Sudden deathFAERS: 2US FAERS
962Suicide attemptFAERS: 2US FAERS
963Symptom recurrenceFAERS: 2US FAERS
964Systemic lupus erythematosus rashFAERS: 2US FAERS
965Temporal ArteritisFAERS: 2US FAERS
966Terminal stateFAERS: 2US FAERS
967Therapeutic product effect variableFAERS: 2US FAERS
968Therapeutic response delayedFAERS: 2US FAERS
969Therapy partial responderFAERS: 2US FAERS
970Toe operationFAERS: 2US FAERS
971Tongue eruptionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
972TorticollisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
973Toxic Shock SyndromeFAERS: 2US FAERS
974Upper respiratory tract inflammationFAERS: 2US FAERS
975UreterolithiasisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
976UrethritisFAERS: 2US FAERS
977Vaginal lesionFAERS: 2US FAERS
978Venous occlusionFAERS: 2US FAERS
979Viral pharyngitisFAERS: 2US FAERS
980Vulvovaginal painFAERS: 2US FAERS
981Waist circumference increasedFAERS: 2US FAERS
982West Nile viral infectionFAERS: 2US FAERS
983Wound dehiscenceFAERS: 2US FAERS
984Wrong drug administeredFAERS: 2US FAERS
985X-ray abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
986YawningFAERS: 2US FAERS
987cancer surgeryFAERS: 2US FAERS
988Abdominal hernia obstructiveFAERS: 1US FAERS
989Abdominal rigidityFAERS: 1US FAERS
990Abnormal weight gainFAERS: 1US FAERS
991Absent bowel movementFAERS: 1US FAERS
992Accidental underdoseFAERS: 1US FAERS
993AcidosisFAERS: 1US FAERS
994Acute sinusitisFAERS: 1US FAERS
995Adnexa uteri massFAERS: 1US FAERS
996Alanine aminotransferase abnormalFAERS: 1US FAERS
997Aldolase increasedFAERS: 1US FAERS
998AmaurosisFAERS: 1US FAERS
999Ammonia abnormalFAERS: 1US FAERS
1000Amputation stump painFAERS: 1US FAERS
1001AmputationFAERS: 1US FAERS
1002Amylase increasedFAERS: 1US FAERS
1003AmyloidosisFAERS: 1US FAERS
1004Anal FistulaFAERS: 1US FAERS
1005Angular cheilitisFAERS: 1US FAERS
1006AnhedoniaFAERS: 1US FAERS
1007Anorectal infectionFAERS: 1US FAERS
1008Antinuclear antibody increasedFAERS: 1US FAERS
1009Aortic RuptureFAERS: 1US FAERS
1010Aortic valve calcificationFAERS: 1US FAERS
1011AortitisFAERS: 1US FAERS
1012Arterial thrombosisFAERS: 1US FAERS
1013Aspartate aminotransferase decreasedFAERS: 1US FAERS
1014AtaxiaFAERS: 1US FAERS
1015Atrial tachycardiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1016Autoimmune PancreatitisFAERS: 1US FAERS
1017Avulsion fractureFAERS: 1US FAERS
1018B-lymphocyte count abnormalFAERS: 1US FAERS
1019BabesiosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1020Bacterial disease carrierFAERS: 1US FAERS
1021Bacterial rhinitisFAERS: 1US FAERS
1022Benign bone neoplasmFAERS: 1US FAERS
1023Benign neoplasm of spinal cordFAERS: 1US FAERS
1024Bladder NeoplasmFAERS: 1US FAERS
1025Bladder discomfortFAERS: 1US FAERS
1026Bladder prolapseFAERS: 1US FAERS
1027Bladder spasmFAERS: 1US FAERS
1028BlepharochalasisFAERS: 1US FAERS
1029Blood 25-hydroxycholecalciferol decreasedFAERS: 1US FAERS
1030Blood alkaline phosphatase abnormalFAERS: 1US FAERS
1031Blood bilirubin decreasedFAERS: 1US FAERS
1032Blood blisterFAERS: 1US FAERS
1033Blood chloride increasedFAERS: 1US FAERS
1034Blood creatine abnormalFAERS: 1US FAERS
1035Blood creatine phosphokinase abnormalFAERS: 1US FAERS
1036Blood electrolytes decreasedFAERS: 1US FAERS
1037Blood folate decreasedFAERS: 1US FAERS
1038Blood folate increasedFAERS: 1US FAERS
1039Blood glucose normalFAERS: 1US FAERS
1040Blood gold increasedFAERS: 1US FAERS
1041Blood homocysteine increasedFAERS: 1US FAERS
1042Blood pH increasedFAERS: 1US FAERS
1043Blood phosphorus decreasedFAERS: 1US FAERS
1044Blood phosphorus increasedFAERS: 1US FAERS
1045Blood pressure inadequately controlledFAERS: 1US FAERS
1046Blood product transfusion dependentFAERS: 1US FAERS
1047Blood sodium abnormalFAERS: 1US FAERS
1048Blood urea abnormalFAERS: 1US FAERS
1049Blood uric acid decreasedFAERS: 1US FAERS
1050Body fat disorderFAERS: 1US FAERS
1051Bone abscessFAERS: 1US FAERS
1052Bone density increasedFAERS: 1US FAERS
1053Bone marrow toxicityFAERS: 1US FAERS
1054BotulismFAERS: 1US FAERS
1055Brain stem syndromeFAERS: 1US FAERS
1056Breast cancer stage IIIFAERS: 1US FAERS
1057Breast discomfortFAERS: 1US FAERS
1058BronchoscopyFAERS: 1US FAERS
1059Burning Mouth SyndromeFAERS: 1US FAERS
1060Bursal fluid accumulationFAERS: 1US FAERS
1061CachexiaFAERS: 1US FAERS
1062Campylobacter infectionFAERS: 1US FAERS
1063Campylobacter sepsisFAERS: 1US FAERS
1064Capillary FragilityFAERS: 1US FAERS
1065Carbon dioxide abnormalFAERS: 1US FAERS
1066Cardiac discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1067Cardiac infectionFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1068Cardiac monitoringFAERS: 1US FAERS
1069Cardiac neoplasm unspecifiedFAERS: 1US FAERS
1070Cardiac stress test abnormalFAERS: 1US FAERS
1071Cardiac ventricular thrombosisFAERS: 1US FAERS
1072Cardio-respiratory distressFAERS: 1US FAERS
1073Cerebrospinal fistulaFAERS: 1US FAERS
1074CheilosisFAERS: 1US FAERS
1075CholangiocarcinomaFAERS: 1US FAERS
1076Chronic Actinic DermatitisFAERS: 1US FAERS
1077Chronic Fatigue SyndromeFAERS: 1US FAERS
1078Coagulation test abnormalFAERS: 1US FAERS
1079Complement factor C3 decreasedFAERS: 1US FAERS
1080Complement factor C4 decreasedFAERS: 1US FAERS
1081Concomitant disease aggravatedFAERS: 1US FAERS
1082Contraindicated drug administeredFAERS: 1US FAERS
1083Contraindicated product prescribedFAERS: 1US FAERS
1084Conversion disorderFAERS: 1US FAERS
1085Corneal InfectionFAERS: 1US FAERS
1086Corneal erosionFAERS: 1US FAERS
1087Counterfeit product administeredFAERS: 1US FAERS
1088Culture urine positiveFAERS: 1US FAERS
1089DactylitisFAERS: 1US FAERS
1090Dermo-hypodermitisFAERS: 1US FAERS
1091Device damageFAERS: 1US FAERS
1092Device malfunctionFAERS: 1US FAERS
1093Device use issueFAERS: 1US FAERS
1094Diastolic hypertensionFAERS: 1US FAERS
1095Diffuse Large B-Cell LymphomaFAERS: 1US FAERS
1096Disease complicationFAERS: 1US FAERS
1097DroolingFAERS: 1US FAERS
1098Drug resistanceFAERS: 1US FAERS
1099Drug withdrawal headacheFAERS: 1US FAERS
1100Duodenal perforationFAERS: 1US FAERS
1101DyscheziaFAERS: 1US FAERS
1102DyschromatopsiaFAERS: 1US FAERS
1103DyspareuniaFAERS: 1US FAERS
1104DysphemiaFAERS: 1US FAERS
1105DysplasiaFAERS: 1US FAERS
1106DystoniaFAERS: 1US FAERS
1107Early satietyFAERS: 1US FAERS
1108EctropionFAERS: 1US FAERS
1109Ejection Fraction DecreasedFAERS: 1US FAERS
1110Elbow operationFAERS: 1US FAERS
1111Electrolyte depletionFAERS: 1US FAERS
1112Electrolyte imbalanceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1113Emergency CareFAERS: 1US FAERS
1114EnophthalmosFAERS: 1US FAERS
1115Enterococcal infectionFAERS: 1US FAERS
1116Enzyme level abnormalFAERS: 1US FAERS
1117EosinophiliaFAERS: 1US FAERS
1118Eosinophilic PneumoniaFAERS: 1US FAERS
1119EpiglottitisFAERS: 1US FAERS
1120Epileptic encephalopathyFAERS: 1US FAERS
1121EpiscleritisFAERS: 1US FAERS
1122Epstein-Barr virus test positiveFAERS: 1US FAERS
1123Euphoric moodFAERS: 1US FAERS
1124Exposure to toxic agentFAERS: 1US FAERS
1125Eye allergyFAERS: 1US FAERS
1126Eye excisionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1127Eyelid painFAERS: 1US FAERS
1128Facial asymmetryFAERS: 1US FAERS
1129Failure to ThriveFAERS: 1US FAERS
1130Failure to suspend medicationFAERS: 1US FAERS
1131False positive investigation resultFAERS: 1US FAERS
1132Febrile infectionFAERS: 1US FAERS
1133Fibrin D dimer increasedFAERS: 1US FAERS
1134Fluid replacementFAERS: 1US FAERS
1135Foaming at mouthFAERS: 1US FAERS
1136Food aversionFAERS: 1US FAERS
1137Fracture infectionFAERS: 1US FAERS
1138FrustrationFAERS: 1US FAERS
1139Full blood count increasedFAERS: 1US FAERS
1140Fungal test positiveFAERS: 1US FAERS
1141Gallbladder adenocarcinomaFAERS: 1US FAERS
1142Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
1143GangreneFAERS: 1US FAERS
1144Gastric DilatationFAERS: 1US FAERS
1145Gastritis herpesFAERS: 1US FAERS
1146Gastroduodenitis haemorrhagicFAERS: 1US FAERS
1147Gastrointestinal bacterial infectionFAERS: 1US FAERS
1148Gastrointestinal bacterial overgrowthFAERS: 1US FAERS
1149Gastrointestinal lymphomaFAERS: 1US FAERS
1150Gastrointestinal procedural complicationFAERS: 1US FAERS
1151Gastrointestinal stenosisFAERS: 1US FAERS
1152Gastrointestinal wall thickeningFAERS: 1US FAERS
1153Gene MutationFAERS: 1US FAERS
1154General symptomFAERS: 1US FAERS
1155Genital abscessFAERS: 1US FAERS
1156Genital painFAERS: 1US FAERS
1157Genital swellingFAERS: 1US FAERS
1158GiardiasisFAERS: 1US FAERS
1159Gingival blisterFAERS: 1US FAERS
1160Gingival pruritusFAERS: 1US FAERS
1161GlomerulonephritisFAERS: 1US FAERS
1162Glossopharyngeal NeuralgiaFAERS: 1US FAERS
1163Gluten sensitivityFAERS: 1US FAERS
1164Granulomatous dermatitisFAERS: 1US FAERS
1165Growth of eyelashesFAERS: 1US FAERS
1166Hair injuryFAERS: 1US FAERS
1167Head titubationFAERS: 1US FAERS
1168Heart alternationFAERS: 1US FAERS
1169Heat StrokeFAERS: 1US FAERS
1170Hepatic EncephalopathyFAERS: 1US FAERS
1171Hepatic Vein ThrombosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1172Hepatic vein dilatationFAERS: 1US FAERS
1173Hepatitis AFAERS: 1US FAERS
1174Hepatitis B DNA decreasedFAERS: 1US FAERS
1175Hepatitis B antibody abnormalFAERS: 1US FAERS
1176Hepatitis B antibody positiveFAERS: 1US FAERS
1177Hepatitis B core antibody positiveFAERS: 1US FAERS
1178Hepatitis B surface antibody positiveFAERS: 1US FAERS
1179Hepatitis C virus test positiveFAERS: 1US FAERS
1180Herpes Zoster OticusFAERS: 1US FAERS
1181Hormone level abnormalFAERS: 1US FAERS
1182HyperacusisFAERS: 1US FAERS
1183HypercapniaFAERS: 1US FAERS
1184HyperparathyroidismFAERS: 1US FAERS
1185HyperpyrexiaFAERS: 1US FAERS
1186HyperreflexiaFAERS: 1US FAERS
1187HypersplenismFAERS: 1US FAERS
1188Hypertrophic CardiomyopathyFAERS: 1US FAERS
1189Hypertrophic osteoarthropathyFAERS: 1US FAERS
1190HypospermiaFAERS: 1US FAERS
1191HypoventilationFAERS: 1US FAERS
1192IleusFAERS: 1US FAERS
1193Immune thrombocytopenic purpuraFAERS: 1US FAERS
1194Inability to afford medicationFAERS: 1US FAERS
1195Inadequate analgesiaFAERS: 1US FAERS
1196Inappropriate affectFAERS: 1US FAERS
1197Incarcerated herniaFAERS: 1US FAERS
1198Incision site abscessFAERS: 1US FAERS
1199Incision site infectionFAERS: 1US FAERS
1200Incision site painFAERS: 1US FAERS
1201Incisional herniaFAERS: 1US FAERS
1202IndurationFAERS: 1US FAERS
1203Infected bunionFAERS: 1US FAERS
1204Infected fistulaFAERS: 1US FAERS
1205Infected neoplasmFAERS: 1US FAERS
1206Infectious pleural effusionFAERS: 1US FAERS
1207Influenza A virus testFAERS: 1US FAERS
1208Injection site bruisingFAERS: 1US FAERS
1209Injection site erythemaFAERS: 1US FAERS
1210Injection site infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1211Injection site massFAERS: 1US FAERS
1212Injection site painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1213Injection site pruritusFAERS: 1US FAERS
1214Injection site warmthFAERS: 1US FAERS
1215Intentional drug misuseFAERS: 1US FAERS
1216Intermittent ClaudicationFAERS: 1US FAERS
1217Intraductal papillary mucinous neoplasmFAERS: 1US FAERS
1218IntussusceptionFAERS: 1US FAERS
1219Invasive Lobular Breast CarcinomaFAERS: 1US FAERS
1220Investigation abnormalFAERS: 1US FAERS
1221Joint resurfacing surgeryFAERS: 1US FAERS
1222Laboratory test interferenceFAERS: 1US FAERS
1223LaryngospasmFAERS: 1US FAERS
1224LazinessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1225Libido disorderFAERS: 1US FAERS
1226Lichen PlanusFAERS: 1US FAERS
1227Lipase increasedFAERS: 1US FAERS
1228Lipoma of breastFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1229ListeriosisFAERS: 1US FAERS
1230Livedo ReticularisFAERS: 1US FAERS
1231Liver function test decreasedFAERS: 1US FAERS
1232Lobar PneumoniaFAERS: 1US FAERS
1233LordosisFAERS: 1US FAERS
1234Lumbar radiculopathyFAERS: 1US FAERS
1235Lung infection pseudomonalFAERS: 1US FAERS
1236Lung perforationFAERS: 1US FAERS
1237Lupus NephritisFAERS: 1US FAERS
1238Lymphocyte percentage increasedFAERS: 1US FAERS
1239LymphocytosisFAERS: 1US FAERS
1240MacrocytosisFAERS: 1US FAERS
1241Malignant HypertensionFAERS: 1US FAERS
1242Malignant melanoma stage IFAERS: 1US FAERS
1243Mallory-Weiss SyndromeFAERS: 1US FAERS
1244MalocclusionFAERS: 1US FAERS
1245MastocytosisFAERS: 1US FAERS
1246Maternal exposure timing unspecifiedFAERS: 1US FAERS
1247Measles antibody positiveFAERS: 1US FAERS
1248MeaslesFAERS: 1US FAERS
1249Mediastinal massFAERS: 1US FAERS
1250Medical device complicationFAERS: 1US FAERS
1251Meningitis herpesFAERS: 1US FAERS
1252Meniscus operationFAERS: 1US FAERS
1253Metabolic acidosisFAERS: 1US FAERS
1254Metabolic function test abnormalFAERS: 1US FAERS
1255MetaplasiaFAERS: 1US FAERS
1256Metastatic uterine cancerFAERS: 1US FAERS
1257MiliariaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1258Mineral deficiencyFAERS: 1US FAERS
1259Monocyte count decreasedFAERS: 1US FAERS
1260Mucoepidermoid CarcinomaFAERS: 1US FAERS
1261Multi-organ disorderFAERS: 1US FAERS
1262Mumps antibody test positiveFAERS: 1US FAERS
1263Muscle FatigueFAERS: 1US FAERS
1264Muscle SpasticityFAERS: 1US FAERS
1265Mycotic allergyFAERS: 1US FAERS
1266MyelomalaciaFAERS: 1US FAERS
1267Myoclonic EpilepsyFAERS: 1US FAERS
1268Myxoid cystFAERS: 1US FAERS
1269Nail bed infectionFAERS: 1US FAERS
1270Nail discomfortFAERS: 1US FAERS
1271Nasal PolypsFAERS: 1US FAERS
1272Nasal herpesFAERS: 1US FAERS
1273Nasal inflammationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1274Nasal pruritusFAERS: 1US FAERS
1275NecrosisFAERS: 1US FAERS
1276Nephrotic SyndromeFAERS: 1US FAERS
1277Neutrophil percentage decreasedFAERS: 1US FAERS
1278Non-high-density lipoprotein cholesterol increasedFAERS: 1US FAERS
1279Nonspecific reactionFAERS: 1US FAERS
1280Nuclear magnetic resonance imaging spinal abnormalFAERS: 1US FAERS
1281NystagmusFAERS: 1US FAERS
1282Obsessive-Compulsive DisorderFAERS: 1US FAERS
1283Ocular icterusFAERS: 1US FAERS
1284Oil acneFAERS: 1US FAERS
1285OnychalgiaFAERS: 1US FAERS
1286Oral contusionFAERS: 1US FAERS
1287Oral mucosal erythemaFAERS: 1US FAERS
1288Oral mucosal exfoliationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1289Oropharyngeal plaqueFAERS: 1US FAERS
1290Oropharyngeal surgeryFAERS: 1US FAERS
1291Oropharyngitis fungalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1292Osteogenesis ImperfectaFAERS: 1US FAERS
1293OsteolysisFAERS: 1US FAERS
1294Osteonecrosis of JawFAERS: 1US FAERS
1295Otitis MediaFAERS: 1US FAERS
1296Otitis media fungalFAERS: 1US FAERS
1297Ovarian cancer stage IVFAERS: 1US FAERS
1298Oxygen supplementationFAERS: 1US FAERS
1299Palmar erythemaFAERS: 1US FAERS
1300Pancreatic NeoplasmFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1301Pancreatic steatosisFAERS: 1US FAERS
1302PapillomaFAERS: 1US FAERS
1303Paternal exposure during pregnancyFAERS: 1US FAERS
1304Pelvic Inflammatory DiseaseFAERS: 1US FAERS
1305Pelvic abscessFAERS: 1US FAERS
1306Pelvic fluid collectionFAERS: 1US FAERS
1307PemphigusFAERS: 1US FAERS
1308Periorbital swellingFAERS: 1US FAERS
1309Peripheral paralysisFAERS: 1US FAERS
1310Pharyngeal leukoplakiaFAERS: 1US FAERS
1311PhotodermatosisFAERS: 1US FAERS
1312Plantar erythemaFAERS: 1US FAERS
1313PleuropericarditisFAERS: 1US FAERS
1314Poor dental conditionFAERS: 1US FAERS
1315Poor feeding infantFAERS: 1US FAERS
1316Post procedural feverFAERS: 1US FAERS
1317Post procedural pulmonary embolismFAERS: 1US FAERS
1318Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
1319Postoperative abscessFAERS: 1US FAERS
1320Postoperative ileusFAERS: 1US FAERS
1321Postoperative thrombosisFAERS: 1US FAERS
1322Postural Orthostatic Tachycardia SyndromeFAERS: 1US FAERS
1323Precancerous cells presentFAERS: 1US FAERS
1324Precancerous lesion excisionFAERS: 1US FAERS
1325PregnancyFAERS: 1US FAERS
1326Primary gastrointestinal follicular lymphomaFAERS: 1US FAERS
1327ProctitisFAERS: 1US FAERS
1328Product coating issueFAERS: 1US FAERS
1329Product complaintFAERS: 1US FAERS
1330Product container seal issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1331Product contaminationFAERS: 1US FAERS
1332Product dosage form issueFAERS: 1US FAERS
1333Product formulation issueFAERS: 1US FAERS
1334Product packaging quantity issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1335Product physical consistency issueFAERS: 1US FAERS
1336Product prescribing issueFAERS: 1US FAERS
1337Product selection errorFAERS: 1US FAERS
1338Progesterone decreasedFAERS: 1US FAERS
1339Prostatic ObstructionFAERS: 1US FAERS
1340Prostatic painFAERS: 1US FAERS
1341Prosthetic cardiac valve thrombosisFAERS: 1US FAERS
1342Protein total decreasedFAERS: 1US FAERS
1343PterygiumFAERS: 1US FAERS
1344Pulmonary function test decreasedFAERS: 1US FAERS
1345Pulmonary granulomaFAERS: 1US FAERS
1346Pulmonary sepsisFAERS: 1US FAERS
1347Punctate keratitisFAERS: 1US FAERS
1348Purpura FulminansFAERS: 1US FAERS
1349Purulent dischargeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1350Pyoderma GangrenosumFAERS: 1US FAERS
1351RadiculopathyFAERS: 1US FAERS
1352Rebound psoriasisFAERS: 1US FAERS
1353Rectal spasmFAERS: 1US FAERS
1354Rectal tenesmusFAERS: 1US FAERS
1355Red blood cell nucleated morphology presentFAERS: 1US FAERS
1356Red cell distribution width decreasedFAERS: 1US FAERS
1357Renal ColicFAERS: 1US FAERS
1358Renal vascular thrombosisFAERS: 1US FAERS
1359Respiratory syncytial virus bronchiolitisFAERS: 1US FAERS
1360Resting TremorFAERS: 1US FAERS
1361Retinal aneurysmFAERS: 1US FAERS
1362Rheumatoid VasculitisFAERS: 1US FAERS
1363Rheumatoid factor negativeFAERS: 1US FAERS
1364Rocky Mountain Spotted FeverFAERS: 1US FAERS
1365Rubella antibody positiveFAERS: 1US FAERS
1366SchizophreniaFAERS: 1US FAERS
1367SclerodactyliaFAERS: 1US FAERS
1368Shock symptomFAERS: 1US FAERS
1369Shoulder deformityFAERS: 1US FAERS
1370Sinus TachycardiaFAERS: 1US FAERS
1371Skin IndurationFAERS: 1US FAERS
1372Skin lesion inflammationFAERS: 1US FAERS
1373Soft tissue massFAERS: 1US FAERS
1374Solar lentigoFAERS: 1US FAERS
1375Somatic symptom disorderFAERS: 1US FAERS
1376SomnambulismFAERS: 1US FAERS
1377Spinal StenosisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1378Spinal claudicationFAERS: 1US FAERS
1379Spinal cord infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1380Spinal flatteningFAERS: 1US FAERS
1381Spinal fusion acquiredFAERS: 1US FAERS
1382Spinal instabilityFAERS: 1US FAERS
1383Splenic InfarctionFAERS: 1US FAERS
1384SpondylolisthesisFAERS: 1US FAERS
1385Squamous cell carcinoma of lungFAERS: 1US FAERS
1386Staphylococcal abscessFAERS: 1US FAERS
1387Staphylococcus test positiveFAERS: 1US FAERS
1388SteatohepatitisFAERS: 1US FAERS
1389Sudden onset of sleepFAERS: 1US FAERS
1390SuperinfectionFAERS: 1US FAERS
1391Suprapubic painFAERS: 1US FAERS
1392Suspected counterfeit productFAERS: 1US FAERS
1393Swollen joint count increasedFAERS: 1US FAERS
1394Systemic mycosisFAERS: 1US FAERS
1395T-lymphocyte count abnormalFAERS: 1US FAERS
1396TachyphylaxisFAERS: 1US FAERS
1397Tender joint countFAERS: 1US FAERS
1398Tendon discomfortFAERS: 1US FAERS
1399Tendon sheath disorderFAERS: 1US FAERS
1400Therapeutic procedureFAERS: 1US FAERS
1401Therapeutic product ineffectiveFAERS: 1US FAERS
1402ThrombocytosisFAERS: 1US FAERS
1403ThymomaFAERS: 1US FAERS
1404Thyroid cancer stage IFAERS: 1US FAERS
1405Thyroid hormones increasedFAERS: 1US FAERS
1406Tinea CapitisFAERS: 1US FAERS
1407Tinea crurisFAERS: 1US FAERS
1408Tongue erythemaFAERS: 1US FAERS
1409Tongue fungal infectionFAERS: 1US FAERS
1410Tooth AvulsionFAERS: 1US FAERS
1411Tooth repairFAERS: 1US FAERS
1412Total complement activity increasedFAERS: 1US FAERS
1413Toxic Epidermal NecrolysisFAERS: 1US FAERS
1414ToxoplasmosisFAERS: 1US FAERS
1415Tracheal painFAERS: 1US FAERS
1416TracheobronchitisFAERS: 1US FAERS
1417TrichotillomaniaFAERS: 1US FAERS
1418Trigeminal Nerve DisorderFAERS: 1US FAERS
1419TrismusFAERS: 1US FAERS
1420Tuberculin TestFAERS: 1US FAERS
1421Typhoid FeverFAERS: 1US FAERS
1422Upper respiratory tract infection bacterialFAERS: 1US FAERS
1423Urinary sediment presentFAERS: 1US FAERS
1424Urinary tract infection fungalFAERS: 1US FAERS
1425Urinary tract obstructionFAERS: 1US FAERS
1426Urine flow decreasedFAERS: 1US FAERS
1427Urine ketone body presentFAERS: 1US FAERS
1428Varicella Zoster Virus InfectionFAERS: 1US FAERS
1429VaricophlebitisFAERS: 1US FAERS
1430Vascular occlusionFAERS: 1US FAERS
1431Vascular painFAERS: 1US FAERS
1432Vascular procedure complicationFAERS: 1US FAERS
1433Vasculitic rashFAERS: 1US FAERS
1434Vasculitic ulcerFAERS: 1US FAERS
1435Venous InjuryFAERS: 1US FAERS
1436Ventilation perfusion mismatchFAERS: 1US FAERS
1437Ventricular FibrillationFAERS: 1US FAERS
1438Very low density lipoprotein increasedFAERS: 1US FAERS
1439Victim of homicideFAERS: 1US FAERS
1440Victim of spousal abuseFAERS: 1US FAERS
1441Viral load increasedFAERS: 1US FAERS
1442Viral sinusitisFAERS: 1US FAERS
1443Vitreous DetachmentFAERS: 1US FAERS
1444VulvitisFAERS: 1US FAERS
1445Vulvovaginal discomfortFAERS: 1US FAERS
1446Wound ComplicationFAERS: 1US FAERS
1447Wound infection bacterialFAERS: 1US FAERS
1448Wrong product administeredFAERS: 1US FAERS
1449Wrong technique in drug usage processFAERS: 1US FAERS
1450carbuncleFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1451keratoacanthomaFAERS: 1US FAERS
1452oligodendrogliomaFAERS: 1US FAERS
1453pseudomembranous colitisFAERS: 1US FAERS
1454Adnexa uteri painCanada Vigilance: 1Canada Vigilance
1455Alcohol IntoleranceCanada Vigilance: 1Canada Vigilance
1456Birth markCanada Vigilance: 1Canada Vigilance
1457Cervical polypCanada Vigilance: 1Canada Vigilance
1458Drug specific antibodyCanada Vigilance: 1Canada Vigilance
1459Enterocolitis viralCanada Vigilance: 1Canada Vigilance
1460Gingival discomfortCanada Vigilance: 1Canada Vigilance
1461Hallucinations, mixedCanada Vigilance: 1Canada Vigilance
1462Hypertensive urgencyCanada Vigilance: 1Canada Vigilance
1463Intercepted product prescribing errorCanada Vigilance: 1Canada Vigilance
1464Noninfective sialoadenitisCanada Vigilance: 1Canada Vigilance
1465Parasite stool test positiveCanada Vigilance: 1Canada Vigilance
1466Saliva alteredCanada Vigilance: 1Canada Vigilance
1467Swelling of eyelidCanada Vigilance: 2Canada Vigilance
1468Tonsillar erythemaCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.